HUP0402528A2 - Lizintartalmú rágótabletták - Google Patents

Lizintartalmú rágótabletták

Info

Publication number
HUP0402528A2
HUP0402528A2 HU0402528A HUP0402528A HUP0402528A2 HU P0402528 A2 HUP0402528 A2 HU P0402528A2 HU 0402528 A HU0402528 A HU 0402528A HU P0402528 A HUP0402528 A HU P0402528A HU P0402528 A2 HUP0402528 A2 HU P0402528A2
Authority
HU
Hungary
Prior art keywords
chewable tablet
tablet containing
lysine
containing lysine
compliance
Prior art date
Application number
HU0402528A
Other languages
English (en)
Inventor
Michael David Marocchi
Claudia Cappellini
Valter Gianesello
Original Assignee
Boehringer Ingelheim International Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh. filed Critical Boehringer Ingelheim International Gmbh.
Publication of HUP0402528A2 publication Critical patent/HUP0402528A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A jelen találmány egy rágható tablettára vonatkozik, amely megnöveltelfogadhatósággal (compliance) rendelkezik emberek, különösengyermekek és/vagy fiatalok esetében, és amely legalább egy vitamint,adott esetben legalább egy ásványi anyagot, lizint vagy egygyógyszerészetileg elfogadható sóját, legalább egy, a lizinvisszataszító ízét elfedni képes édesítőszert, adott esetben egyízesítőszert és egy gyógyszerészetileg vagy dietetikailag elfogadhatóhordozót tartalmaz. Ó
HU0402528A 2001-10-23 2002-10-23 Lizintartalmú rágótabletták HUP0402528A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152169 2001-10-23
PCT/EP2002/011843 WO2003035027A1 (en) 2001-10-23 2002-10-23 Chewable tablet containing lysine

Publications (1)

Publication Number Publication Date
HUP0402528A2 true HUP0402528A2 (hu) 2005-07-28

Family

ID=7703361

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402528A HUP0402528A2 (hu) 2001-10-23 2002-10-23 Lizintartalmú rágótabletták

Country Status (16)

Country Link
EP (1) EP1439818B1 (hu)
JP (1) JP2005506364A (hu)
AR (1) AR036937A1 (hu)
AT (1) ATE285753T1 (hu)
BR (1) BR0213449A (hu)
CA (1) CA2463259C (hu)
DE (1) DE60202489T2 (hu)
ES (1) ES2236589T3 (hu)
HU (1) HUP0402528A2 (hu)
MX (1) MXPA04003717A (hu)
PL (1) PL368342A1 (hu)
PT (1) PT1439818E (hu)
RU (1) RU2324474C2 (hu)
UA (1) UA78242C2 (hu)
UY (1) UY27505A1 (hu)
WO (1) WO2003035027A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5009616B2 (ja) 2003-08-19 2012-08-22 ファルマトン ソシエテ アノニム 小児又は若年成人のための総合ビタミンシロップ
JP2005272401A (ja) * 2004-03-25 2005-10-06 Tendou Seiyaku Kk チュアブル錠
US20080039422A1 (en) * 2004-03-30 2008-02-14 Transition Therapeutics Inc. Vitamin B12-Containing Compositions and Methods of Use
JP4954450B2 (ja) * 2004-06-14 2012-06-13 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維形成の不全、欠損又は無秩序による病状に対処するための、リシルオキシダーゼのアイソフォームの活性の誘導
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
DE202008006491U1 (de) * 2007-02-23 2008-08-21 Basf Se Verwendung von Azoverbindungen zur Geschmacksmodulation von stofflichen Zusammensetzungen, die mindestens einen High Intensity Sweetener (HIS) enthalten
EP2131811B1 (fr) * 2007-03-14 2020-03-04 Vetinnov Produit appétent
RU2391109C1 (ru) * 2008-12-09 2010-06-10 Открытое Акционерное Общество "Инвестиционная Финансовая Группа "Гленик-М" Средство лечения онкологических заболеваний с использованием изотопа кальций-41
DE202012103733U1 (de) * 2012-09-28 2012-11-15 Reiner Rittinghausen Zusammensetzung zur nutritiven Ergänzung oder Behandlung bei Herpes
SG11201507957VA (en) * 2013-03-27 2015-10-29 Psm Healthcare Ltd Stabilized vitamin d formulations
WO2016046818A1 (en) 2014-09-25 2016-03-31 Nutriteen Professionals Ltd. Nutritional supplements for growth enhancement in pre-pubertal adolescents
CN104688774A (zh) * 2015-02-17 2015-06-10 胡梨芳 包含手性异构化合物的赖氨酸磷酸氢钙药物组合物及其用途
WO2017008902A1 (de) * 2015-07-12 2017-01-19 Cfso Gmbh Cholecalciferolsulfat-salze und deren verwendung zur behandlung von vitamin d3-mangel
ES2725009T3 (es) * 2016-03-04 2019-09-18 Laboratorio Reig Jofre S A Comprimidos con un alto contenido de principios activos útiles para el tratamiento de la pérdida de cabello o la estimulación de su crecimiento
CN107854457A (zh) * 2016-09-22 2018-03-30 刘力 包括手性异构化合物的葡萄糖酸钙锌组合物及其用途
US11547688B2 (en) * 2019-08-22 2023-01-10 Nodari Rizun Amino acid compositions and methods of manufacturing the compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
FR2215950A2 (en) * 1973-02-01 1974-08-30 Union Pharma Scient Appl Carbonated lysine - as carbonate source in effervescent compositions
US3970750A (en) * 1974-10-08 1976-07-20 Sandoz, Inc. Effervescent potassium chloride composition
JPH06227974A (ja) * 1993-01-29 1994-08-16 Kyowa Hakko Kogyo Co Ltd 栄養組成物
US20020081360A1 (en) * 2000-12-27 2002-06-27 Andreas Burgard Salts of L-amino acid having improved taste and their preparation

Also Published As

Publication number Publication date
WO2003035027A1 (en) 2003-05-01
PT1439818E (pt) 2005-03-31
ATE285753T1 (de) 2005-01-15
CA2463259C (en) 2011-01-04
BR0213449A (pt) 2004-11-09
RU2324474C2 (ru) 2008-05-20
JP2005506364A (ja) 2005-03-03
DE60202489T2 (de) 2006-01-05
EP1439818B1 (en) 2004-12-29
UY27505A1 (es) 2003-06-30
CA2463259A1 (en) 2003-05-01
AR036937A1 (es) 2004-10-13
RU2004115755A (ru) 2005-04-10
ES2236589T3 (es) 2005-07-16
DE60202489D1 (de) 2005-02-03
MXPA04003717A (es) 2004-07-30
EP1439818A1 (en) 2004-07-28
PL368342A1 (en) 2005-03-21
UA78242C2 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
HUP0402528A2 (hu) Lizintartalmú rágótabletták
HUP0204382A2 (hu) Javított gyermektápszer-készítmény és eljárás táplálásra és tolerancia fokozására
HUP0402293A2 (hu) Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására
NO20004190D0 (no) Oralt administrerbar galenisk form med umiddelbar frigivelse og langvarig frigivelse som omfatter et absorpsjonsfremmende middel, og anvendelse av dette absorpsjonsfremmende middel
HUP0104318A2 (hu) cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények
HRP20041152B1 (en) Pharmaceutical formulations
NO2012009I2 (no) Kombinasjonsprodukt av saxaglipin og metformin og farmasøytisk akseptable salter derav, herunder HCIsaltene av saxaglipin og metformin
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
IT1264494B1 (it) Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
GR1004522B (el) Φαρμακευτικη συνθεση
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
AU2002234851A1 (en) C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
HUP0002455A2 (hu) Gyomorban maradó gyógyszerészeti készítmény
HUP0202324A2 (hu) Prukaloprid orális oldat
HUP0202119A2 (hu) OCIF-ot és poliszacharidot tartalmazó komplex
ATE338567T1 (de) Pharmazeutische zubereitungen, wirkstoffe enthaltend, die sich für unerlaubte verabreichung anbieten
ATE238034T1 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
HUP0401940A2 (hu) Diabetikus neuropátia esetében alkalmazható gyógyszerkészítmény
DE50309337D1 (de) Calcium enthaltende süssigkeit
NO20044519L (no) Hyperforinderivater, anvendelse derav samt formuleringer som inneholder dem
EE05184B1 (et) Kaloporosiidi derivaadid, nende valmistamine ja kasutamine ravimina, neid sisaldavad ravimid ning mikroorganismi Gloeoporus dichrous (Fr.:Fr.) tvi ST001714 (DSM 13784)
WO2004054494A3 (en) Teething devices

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees